Boston Scientific Corporation company logo

# RNN 1st Gen Model Boston Scientific Corporation Surgical & medical instruments

Prediction models:
Subscribe >> Deal exit on
Feb. 22, 2018
Deal entry on
Feb. 22, 2018
0.40%Expected margin
74.42% successful of 43 deals
$ 26.48 Last close price
at 22-feb-2018


Model's trade recommendations 4.43% Return for period

8.72% Annual return

$36.89B Market Cap

β 0.81  


Model (following trade recommendations)


Underlying stock

S&P 500

Return for period 4.43%
52wk return 13.09%
52wk Range
Sortino ratio 2.01
Sharpe ratio 1.12
Norm. RMSE 0.61%
Downside risk 4.14%
Volatility 7.43%
  • STRONG BUY Analysts consensus recommendation

Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.

Industry sector: Medical

Sector classification: Surgical & medical instruments

Deep Learning based analysis and prediction model for Boston Scientific Corporation (BSX) stock is a 1st Generation Non-linear Autoregresive with exogenous variable(s) (NARX) model based on the Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for BSX model training are being downloaded from the Quandl premium datasets on a daily basis.

Model is being retrained on a daily basis.

Float 1363M
P/E 21.29
Shares Outstanding 1375M
% Held by Insiders 0.74%
% Held by Institutions 87.77%
EPS (last reported FY) $1.26
EPS (last reported Q) $0.34
EPS, estimated (last reported Q) $0.34
Total revenues $9 B
Net income $0 B